Luna, Sofia E. http://orcid.org/0000-0002-9173-9518
Camarena, Joab http://orcid.org/0000-0002-3102-5820
Hampton, Jessica P. http://orcid.org/0000-0002-0084-5404
Majeti, Kiran R.
Charlesworth, Carsten T.
Soupene, Eric
Selvaraj, Sridhar
Jia, Kun
Sheehan, Vivien A. http://orcid.org/0000-0003-2837-2255
Cromer, M. Kyle http://orcid.org/0000-0002-8198-5010
Porteus, Matthew H. http://orcid.org/0000-0002-3850-4648
Funding for this research was provided by:
American Society of Hematology (Junior Faculty Scholar Award, Minority Medical Student Award, Minority Medical Student Award)
SU | School of Medicine, Stanford University (Medical Scientist Training Program, Stanford Medical Scholars Research Program)
Article History
Received: 17 August 2023
Accepted: 2 May 2024
First Online: 17 June 2024
Competing interests
: M.H.P. serves on the scientific advisory board of Allogene Tx and is an advisor to Versant Ventures. M.H.P., M.K.C. and J.C. have equity in Graphite Bio. M.H.P. has equity in CRISPR Tx and serves on the board of directors of Graphite Bio and Kamau Therapeutics. J.C., M.K.C. and M.H.P. have filed provisional patent number PCT/US2022/077951. All other authors declare no competing interests.